Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Associate Partners:

  • Kotak Mutual Fund
  • Pharmeasy
  • Indiabulls
  • State Bank of India
  • CoinSwitch Kuber

Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Technology Partner

Dell Technologies

Associate Partners

Kotak Mutual Fund
Pharmeasy
Indiabulls
State Bank of India
CoinSwitch Kuber
stock views
Jump to
442 Results Found
  • Lupin may test Rs 2600-2700: Prakash Diwan Sep 24, 2015 04:42 PM IST

    Lupin may test Rs 2600-2700: Prakash Diwan

    Prakash Diwan of prakashdiwan.in is of the view that Lupin may test Rs 2600-2700.

  • Positive on Sun Pharma, Strides Arcolab: Deepak Shenoy Sep 24, 2015 01:25 PM IST

    Positive on Sun Pharma, Strides Arcolab: Deepak Shenoy

    Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.

  • Like Sun Pharma, Strides Arcolab: Deepak Shenoy Aug 25, 2015 04:36 PM IST

    Like Sun Pharma, Strides Arcolab: Deepak Shenoy

    Deepak Shenoy, Founder of Capitalmind.in likes Sun Pharma and Strides Arcolab and feels that pharma as a space is worth looking into.

  • Wait 2-3 qtrs to buy Lupin, Sun Pharma: Prabhudas Lilladher Jul 24, 2015 02:02 PM IST

    Wait 2-3 qtrs to buy Lupin, Sun Pharma: Prabhudas Lilladher

    Pharma Analyst Surajit Pal is not very keen on holding pharma biggies, given the newsflows that are associated with them. Lupin first quarter earnings have been disappointing and Pal believes the pain is going to continue for two-three months. Another big-ticket stock Sun Pharma too have seen a steep fall after it issued profit warning.

  • Accumulate Sun Pharma with 18-24 months view: Devang Mehta Jul 21, 2015 03:55 PM IST

    Accumulate Sun Pharma with 18-24 months view: Devang Mehta

    Devang Mehta of Anand Rathi Financial Services recommends accumulating Sun Pharmaceutical Industries with a view of 18-24 months.

  • Prefer Glenmark Pharma: Anand Tandon Jun 04, 2015 04:32 PM IST

    Prefer Glenmark Pharma: Anand Tandon

    Anand Tandon, Market Expert is of the view that one may prefer Glenmark Pharma.

  • Buy Sun Pharmaceutical Industries: Mahantesh Sabarad Jun 03, 2015 01:30 PM IST

    Buy Sun Pharmaceutical Industries: Mahantesh Sabarad

    Mahantesh Sabarad, Deputy VP of Research at SBI Capital Securities recommends buying Sun Pharmaceutical Industries.

  • See downside of 5-7% in Sun Pharma: Sachin Shah Jun 01, 2015 02:03 PM IST

    See downside of 5-7% in Sun Pharma: Sachin Shah

    Sachin Shah of Emkay Investment Managers is of the view that one may see 5-7 percent downside in Sun Pharmaceutical Industries.

  • Prefer Strides Arcolab, Sun Pharma: Deepak Shenoy Apr 28, 2015 11:30 AM IST

    Prefer Strides Arcolab, Sun Pharma: Deepak Shenoy

    Deepak Shenoy of Capital Mind is of the view that one may prefer Strides Arcolab and Sun Pharma.

  • Hold Reliance Industries; target Rs 980: Gaurang Shah Apr 10, 2015 03:46 PM IST

    Hold Reliance Industries; target Rs 980: Gaurang Shah

    Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may hold Reliance Industries with a target Rs 980.

  • Hold Sun Pharma: Mayuresh Joshi Apr 06, 2015 04:28 PM IST

    Hold Sun Pharma: Mayuresh Joshi

    Mayuresh Joshi - fund manager - PMS at Angel Broking recommends holding Sun Pharma.

  • Check out: Investment ideas by market experts Apr 01, 2015 04:18 PM IST

    Check out: Investment ideas by market experts

    Watch the interview of Mayuresh Joshi of Angel Broking to answer all your stock queries and Kalpesh Ashar of Full Circle Financial Planners & Advisors is answer our few personal finance queries.

  • Stay invested in Sun Pharma: Mayuresh Joshi Apr 01, 2015 04:07 PM IST

    Stay invested in Sun Pharma: Mayuresh Joshi

    According to Mayuresh Joshi of Angel Broking, one may stay invested in Sun Pharmaceutical Industries.

  • Expect upside in Sun Pharma: Abhishek Sharma Mar 26, 2015 02:28 PM IST

    Expect upside in Sun Pharma: Abhishek Sharma

    Abhishek Sharma, pharma analyst at IIFL is of the view that one may see upside in Sun Pharmaceutical Industries.

  • Positive on Lupin on strong pipeline for US mkt: IIFL Mar 26, 2015 12:27 PM IST

    Positive on Lupin on strong pipeline for US mkt: IIFL

    Pharma Analyst, Abhishek Sharma of IIFL spoke with Ekta Batra & Anuj Singhal of CNBC-TV18. He shared his reading and outlook on the pharmaceutical space.

  • Invest in Sun Pharma, says Mayuresh Joshi Mar 25, 2015 03:31 PM IST

    Invest in Sun Pharma, says Mayuresh Joshi

    Mayuresh Joshi of Angel Broking is of the view that one may invest in Sun Pharmaceutical Industries.

  • See 10% overall growth for Sun-Ranbaxy entity: Surajit Pal Mar 25, 2015 02:21 PM IST

    See 10% overall growth for Sun-Ranbaxy entity: Surajit Pal

    or the investors who are holding the stock should continue to hold it but fresh entry should be made only if it corrects from the current levels, says Surajit Pal, pharma analyst at Prabhudas Lilladher.

  • Here are top 10 stocks to focus on March 24 Mar 24, 2015 08:48 AM IST

    Here are top 10 stocks to focus on March 24

    Here are top 10 stocks to focus on March 24 – HDFC, Wockhardt, Geometric, GMR Infra, Sun Pharma, Ranbaxy, Hero Moto, JSPL, Adani Power and Aarti Drugs.

  • Exit Biocon, says Vishal Malkan Mar 20, 2015 03:29 PM IST

    Exit Biocon, says Vishal Malkan

    Vishal Malkan of malkansview.com is of the view that one may exit Biocon.

  • Pharma safe space: Sandip Sabharwal Mar 09, 2015 11:00 AM IST

    Pharma safe space: Sandip Sabharwal

    Sandip Sabharwal of asksandipsabharwal.com is of the view that pharma could be a safe pocket.

  • Buy Ranbaxy Labs 780 Call: VK Sharma Mar 05, 2015 11:05 AM IST

    Buy Ranbaxy Labs 780 Call: VK Sharma

    VK Sharma of HDFC Securities recommends buying Ranbaxy Labs 780 Call.

  • Here are top 10 stocks to focus on March 4 Mar 04, 2015 08:54 AM IST

    Here are top 10 stocks to focus on March 4

    Here are top 10 stocks to focus on March 4 - MindTree, Tata Global Beverages, Eicher Motors, Bharti Airtel, Idea Cellular, Adani Ports, Adani Power, Sesa Sterlite, JSPL and Nitesh Estates. The research team at CNBC-TV18 is also tracking Tata Motors, Ranbaxy, L&T Finance Holdings and APL Apollo Tubes.

  • Prefer Sun Pharma, says Neeraj Deewan Feb 11, 2015 05:24 PM IST

    Prefer Sun Pharma, says Neeraj Deewan

    Neeraj Deewan of Quantum Securities prefers Sun Pharmaceutical Industries.

  • Buy Lupin 1600 Call, Ranbaxy 740 Call: VK Sharma Feb 05, 2015 09:47 AM IST

    Buy Lupin 1600 Call, Ranbaxy 740 Call: VK Sharma

    VK Sharma of HDFC Securities is of the view that one may buy Lupin 1600 Call and Ranbaxy Labs 740 Call.

  • Buy Ranbaxy, Apollo Tyres: Meghana Malkan Feb 02, 2015 03:11 PM IST

    Buy Ranbaxy, Apollo Tyres: Meghana Malkan

    Meghana V Malkan of malkansview.com is of the view that one may buy Ranbaxy Laboratories and Apollo Tyres.

Sections
ISO 27001 - BSI Assurance Mark